Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Maastricht University · Aberdeen Royal Infirmary · +17 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
572
total citations
- FWCI
- 138.34
- Percentile
- 100%
- References
- 105
Citations per year
Authors
12Topics & keywords
Topics
Keywords
- Medicine
- Guideline
- Oncology
- Lung cancer
- Internal medicine
- Cancer
- Clinical Practice
- Intensive care medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- AAAmerican Association for Cancer Research
- AAmgen
- ELEli Lilly and Company
- PPfizerAward: 2020-2022
- AAstraZeneca
- SSanofi
- GSGilead Sciences
- IAInternational Association for the Study of Lung Cancer
- ASAmerican Society of Clinical Oncology
- CCelgene
- AIAssociazione Italiana di Oncologia Medica
- RPRegeneron Pharmaceuticals
- NNovocure
- LLLes Laboratories Pierre Fabre
- BBeiGene
- IIncyte
- DKDeutsche Krebshilfe
- ESEuropean Society for Medical Oncology
- CSChinese Society of Clinical Oncology
- SASchweizerische Arbeitsgemeinschaft für Klinische Krebsforschung
- PPharmaMar
- HKHong Kong Cancer Fund
- GGenentech
- SSamsung
- FMFoundation Medicine
- CCCancer Council Victoria
- DSDaiichi Sankyo Europe